The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Lishchuk S.V.

GU "Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo"

Kazantseva I.A.

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Dubova E.A.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Pavlov K.A.

ZAO «Evropejskij meditsinskij tsentr», Moskva, Rossija, 123104

Katunina O.R.

Health Department State Dermatovenerological Research Centre, Moscow

Borbat A.M.

A.I. Burnazyan Federal Medical and Biophysical Center, Federal Biomedical Agency of Russia, Moscow, Russia

Udalov Iu.D.

Gorodskaia klinicheskaia bol'nitsa #40 Departamenta zdravookhraneniia Moskvy

Morphological features of IgG4-related lesions at various sites

Authors:

Lishchuk S.V., Kazantseva I.A., Dubova E.A., Pavlov K.A., Katunina O.R., Borbat A.M., Udalov Iu.D.

More about the authors

Read: 11784 times


To cite this article:

Lishchuk SV, Kazantseva IA, Dubova EA, Pavlov KA, Katunina OR, Borbat AM, Udalov IuD. Morphological features of IgG4-related lesions at various sites. Russian Journal of Archive of Pathology. 2019;81(5):22‑29. (In Russ.)
https://doi.org/10.17116/patol20198105122

References:

  1. Kazantseva IA, Lishchuk SV. IgG4-related sclerosing disease — a new systemic pathology. Klinicheskaya i eksperimental’naya morfologiya. 2013;2(6):12-17. (In Russ.)
  2. Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Klöppel G, Heathcote JG, Khosroshahi A, Ferry JA, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181-1192. https://doi.org/10.1038/modpathol.2012.72
  3. Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease. Clin Exp Immunol. 2015;181(2):191-206. https://doi.org/10.1186/s40463-015-0071-9
  4. Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy. 2009;39:469-477. https://doi.org/10.1111/j.1365-2222.2009.03207.x
  5. Uchida K, Okazaki K. Clinical and pathophysiological aspects of type 1 autoimmune pancreatitis. J Gastroenterol. 2018;53(4):475-483. https://doi.org/10.1007/s00535-018-1440-8
  6. Xiao X, Lian M, Zhang W, Eric Gershwin M, Ma X. The immunologic paradoxes of IgG4-related disease. Clin Rev Allergy Immunol. 2018;54(2):344-351. https://doi.org/10.1007/s12016-018-8679-y
  7. Sato Y., Kojima M, Takata K, Morito T, Mizobuchi K, Tanaka T, Inoue D, Shiomi H, Iwao H, Yoshino T. Multicentric Castleman’s disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J Clin Pathol. 2010;63(12):1084-1089. https://doi.org/10.1136/jcp.2010.082958
  8. Dhall D, Suriawinata AA, Tang LH, Shia J, Klimstra DS. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis. Hum Pathol. 2010;41(5):643-52. https://doi.org/10.1016/j.humpath.2009.10.019
  9. Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol. 2010;17:303-332. https://doi.org/10.1097/PAP.0b013e3181ee63ce
  10. Zen Y, Nakanuma Y. IgG4-related disease: a crosssectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812-1819.
  11. Matsubayashi H, Kakushima N, Takizawa K, Tanaka M, Imai K, Hotta K, Ono H. Diagnosis of autoimmune pancreatitis. World J Gastroenterol. 2014;20(44):16559-16569. https://doi.org/10.3748/wjg.v20.i44.16559
  12. Mulholland GB, Jeffery CC, Satija P, Côté DW. Immunoglobulin G4-related diseases in the head and neck: a systematic review. J Otolaryngol Head Neck Surg. 2015;44:24. https://doi.org/10.1186/s40463-015-0071-9
  13. Vasil’ev VI, Safonova TN, Sokol EV, Probatova NA, Kokosadze NV, Pavlovskaya AI, Kovrigina AM, Radenska-Lopovok SG, Gorodetskii VR, Rodionova EB, Pal’shina SG, Aleksandrova EN, Shornikova NS, Gaiduk IV. Diagnosis of IgG4-related ophthalmic disease in a group of patients with various lesions of the eye and orbits. Terapevticheskiy arkhiv. 2018;90(5):61-71. (In Russ.) https://doi.org/10.26442/terarkh201890561-71
  14. Mizushima I, Yamada K, Harada K, Matsui S, Saeki T, Kondo S, Takahira M, Waseda Y, Hamaguchi Y, Fujii H, Yamagishi M, Kawano M. Diagnostic sensitivity of cutoff values of IgG4-positive plasma cell number and IgG4-positive/CD138-positive cell ratio in typical multiple lesions of patients with IgG4-related disease. Mod Rheumatol. 2018;28(2):293-299. https://doi.org/10.1080/14397595.2017.1332540
  15. Geyer JT, Ferry JA, Harris NL, Stone JH, Zukerberg LR, Lauwers GY, Pilch BZ, Deshpande V. Chronic sclerosing sialadenitis (Kuttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010;34(2):202-210. https://doi.org/10.1097/PAS.0b013e3181c811ad
  16. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011;64(3):237-243. https://doi.org/10.1136/jcp.2010.085613
  17. Hamaguchi Y, Yamada K, Kawano M, Fujimoto M, Takehara K. Prurigo nodularis-like skin eruptions in a patient with IgG4-related disease. Eur J Dermatol. 2013;23(4):541-542. https://doi.org/10.1684/ejd.2013.2077
  18. Ikeda T, Oka M, Shimizu H, Hatakeyama M, Kanki H, Kunisada M, Tsuji G, Morinobu A, Kumagai S, Azumi A, Negi A, Nishigori C. IgG4-related skin manifestations in patients with IgG4-related disease. Eur J Dermatol. 2013;23(2):241-245. https://doi.org/10.1684/ejd.2013.1958
  19. Jalilian C, Prince HM, McCormack C, Lade S, Cheah CY. IgG4-related disease with cutaneous manifestations treated with rituximab: case report and literature review. Australas J Dermatol. 2014;55(2):132-136. https://doi.org/10.1111/ajd.12100
  20. Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, Nakada S, Matsui S, Origuchi T, Nishiyama S, et al. Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol. 2012;2012:580814. https://doi.org/10.1155/2012/580814 Received 16.01.19

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.